Cargando…

Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”

Detalles Bibliográficos
Autores principales:	Linschoten, Marijke, Nab, Linda, van der Horst, Iwan C.C., Tieleman, Robert, Asselbergs, Folkert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725132/ https://www.ncbi.nlm.nih.gov/pubmed/33310109 http://dx.doi.org/10.1016/j.ijid.2020.12.006

Ejemplares similares

Response to correspondence concerning: “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
por: Lammers, A.J.J., et al.
Publicado: (2021)

Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients
por: Lammers, A.J.J., et al.
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine
por: Verheijen, S., et al.
Publicado: (2021)

Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)

Chloroquine/hydroxychloroquine overdose
por: McKeever, Rita
Publicado: (2020)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
por: Biswas, Partha Sarathi, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine for cancer therapy
por: Manic, Gwenola, et al.
Publicado: (2014)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
por: Stevens, David M., et al.
Publicado: (2020)

Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy
por: Kamphuis, Janine A. M., et al.
Publicado: (2020)

Hydroxychloroquine- and chloroquine-related cardiovascular events
Publicado: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

The impact of pre-existing hypertension and its treatment on outcomes in patients admitted to hospital with COVID-19
por: McFarlane, Ewan, et al.
Publicado: (2022)

Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given
por: Malviya, Amit
Publicado: (2020)

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
por: Li, Qiuyu, et al.
Publicado: (2021)

ICU admission and favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Comparison of hospital treatment strategy or of treatment actually received in COVID-19?: Commenting on: Lammers AJJ, Brohet RM, Theunissen REP, Koster C, Rood R, Verhagen DWM, et al. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients. Int J Infect Dis. 2020 September
por: Sikkens, Jonne J., et al.
Publicado: (2021)

Cardiac complications in patients hospitalised with COVID-19
por: Linschoten, Marijke, et al.
Publicado: (2020)

Self-perceived recovery and quality of life in elderly patients surviving ICU-admission for abdominal sepsis
por: Cuijpers, Anne C.M., et al.
Publicado: (2021)

Sex differences in cardiovascular complications and mortality in hospital patients with covid-19: registry based observational study
por: Hockham, Carinna, et al.
Publicado: (2023)

The parent drugs chloroquine and hydroxychloroquine do not inhibit human CYP3A activity in vitro
por: Li, Xia, et al.
Publicado: (2020)

Side Effects of Chloroquine and Hydroxychloroquine on Skeletal Muscle: a Narrative Review
por: Carvalho, Alzira Alves de Siqueira
Publicado: (2020)

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
por: Gies, Vincent, et al.
Publicado: (2020)

Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
por: Lebin, Jacob A., et al.
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review
por: Fernandes, Carolina Pereira, et al.
Publicado: (2022)

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
por: Singh, Bhagteshwar, et al.
Publicado: (2021)

Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
por: Shetty, Rajesh M, et al.
Publicado: (2021)

Cardiotoxicity of chloroquine and hydroxychloroquine through mitochondrial pathway
por: Seydi, Enayatollah, et al.
Publicado: (2023)

Chloroquine and Hydroxychloroquine in the Treatment of Dry Eye Disease
por: Prinz, Julia, et al.
Publicado: (2023)

Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir
por: Guner, Rahmet, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_el13pbtgkp5h0ode10n4ata7rp